{"schema_version":"1","generated_at":"2026-10-29T07:53:17.911Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ahmad-zarzour","json_url":"https://www.findmykol.com/kol/ahmad-zarzour/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ahmad-zarzour","name":"Ahmad Zarzour","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Toledo","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1992149041","openalex":"A5108554103"},"summary":"Ahmad Zarzour is an Oncology physician. OpenAlex indexes 18 publications with 262 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":18,"cited_by_count":262,"h_index":5,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":40,"program_years":{"first":2021,"last":null},"rows_total":78,"shown":3,"withheld":75,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":45.34,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992149041"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":31.79,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992149041"},{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":30.72,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992149041"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1992149041","source":"payments"},"prescribing":{"data_year":2024,"areas_total":11,"areas_shown":3,"areas":[{"area":"Sensory organs","share_pct":45.8,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"mixed","share_pct":45.8,"drugs":[{"name":"Dexamethasone sodium phosphate","share_pct":91.8},{"name":"Dexamethasone","share_pct":8.2}],"max_beneficiaries":28}]},{"area":"Cancer & immunology","share_pct":18.5,"classes_total":5,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":6.1,"drugs":[{"name":"Brukinsa","share_pct":62.2},{"name":"Calquence","share_pct":22.2},{"name":"Ibrance","share_pct":15.6}],"max_beneficiaries":null},{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":6,"drugs":[{"name":"Anastrozole","share_pct":100}],"max_beneficiaries":28}]},{"area":"Blood & clotting","share_pct":6.8,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":5.3,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":16},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":1.5,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":86.3,"facility_pct":13.7},"source":"medicare"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"OpenAlex author record","recent":[{"title":"Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa).","year":2020,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e17517","status":"verified"},{"title":"Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa).","year":2019,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps333","status":"verified"},{"title":"Adverse Effects of Androgen Deprivation in Elderly Men with Prostate Cancer","year":2019,"journal":"Current Geriatrics Reports","source_url":"https://doi.org/10.1007/s13670-019-00303-8","status":"verified"},{"title":"Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best","year":2016,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.v128.22.50.50","status":"verified"},{"title":"The Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis","year":2015,"journal":"Nutrition and Cancer","source_url":"https://doi.org/10.1080/01635581.2015.1082109","status":"verified"}],"source":"works"},"contact":{"address_1":"4126 N HOLLAND SYLVANIA RD STE 105","city":"Toledo","state":"OH","zip":"436233541","phone":"419-479-5605","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1992149041","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":75,"publications":13}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-04-15","provider_certified":"2025-04-15","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}